NCT02056210View on ClinicalTrials.gov

Stem Cell Mobilization With Plerixafor in Diabetic vs Control Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Diabetes
Interventions
DRUG

Mozobil

Subcutaneous injection of 0.24 mg/kg Mozobil once at 8:30am

Trial Locations (1)

35128

Policlinico Universitario, Azienda Ospedaliera di Padova, Padua

All Listed Sponsors
collaborator

Azienda Ospedaliera di Padova

OTHER

lead

University of Padova

OTHER

NCT02056210 - Stem Cell Mobilization With Plerixafor in Diabetic vs Control Subjects | Biotech Hunter | Biotech Hunter